Douglas Campbell
Head of Research and Development
Cancer
mi nomic
Australia
Biography
Dr. Douglas Campbell is the Head of Research and Development and leads Minomic’s scientific team. Dr. Campbell has nearly 20 years of experience in biomedical research with a particular focus on drug development and oncology. Most recently, he was involved in the development of a novel antibody (MDX-1097) from pre-clinical to Phase 2 clinical trials. After a Ph.D. in cancer biology at the Garvan Institute of Medical Research and post-doctoral research at the Imperial Cancer Research Fund in London, he joined Apollo Life Sciences as a team leader responsible for the development of recombinant protein expression and scale-up strategies. He is also a co-founder of iClinix, a medical software company specializing in oncology, pharmacy and transplantation management systems
Research Interest
Cancer
